Lakefront Biotherapeutics | GLPG - Pre Tax Profit


Lakefront Biotherapeutics reported EUR13.96M in Pre-Tax Profit for its fiscal quarter ending in March of 2026.





Pre Tax Profit Change Date
argenx SE USD 426M 22.71M Mar/2026
AstraZeneca USD 4.81B 894M Jun/2026
Biogen USD 647.3M 269.6M Jun/2026
Genmab DKK 295M 221M Jun/2026
Gilead Sciences USD -7.53B 10.11B Jun/2026
GlaxoSmithKline GBP 2.68B 532M Jun/2026
GRIFOLS EUR 247M 135M Jun/2026
Hikma Pharmaceutical USD 147.5M 3.5M Jun/2025
Incyte USD 751.51M 407.91M Jun/2026
Merck EUR 869M 468M Mar/2026
Neurocrine Biosciences USD 246.8M 7.4M Mar/2026
Novartis USD 4.27B 430M Jun/2026
Roche Holding CHF 11.17B 6.38B Jun/2026
Sanofi EUR 837M 1.17B Jun/2026
UCB EUR 789M 427M Jun/2025
Vertex Pharmaceuticals USD 1.25B 78.1M Mar/2026